When "flawed" translates into "flood": the unproven association between cancer incidence and glargine insulin therapy

Oncologist. 2009 Dec;14(12):1175-7. doi: 10.1634/theoncologist.2009-0278. Epub 2009 Dec 10.

Authors

Jose M de Miguel-Yanes¹, James B Meigs

Affiliation

¹ Harvard Medical School, General Medicine Division, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.

PMID: 20007646
DOI: 10.1634/theoncologist.2009-0278

No abstract available

MeSH terms

Humans
Incidence
Insulin / administration & dosage
Insulin / adverse effects
Insulin / analogs & derivatives*
Insulin Glargine
Insulin, Long-Acting
Neoplasms / chemically induced*
Neoplasms / epidemiology
Risk Factors

Substances

Insulin
Insulin, Long-Acting
Insulin Glargine